GNRHR and central precocious puberty: GnRH-a are widely used in the treatment of various pediatric conditions, including CPP, where they are considered the standard of care: they exert their effects by binding to GnRH receptors, leading to the desensitization of pituitary gonadotrophins and the subsequent suppression of gonadal steroid secretion [2,3].